Impact Journals News
Latest Posts
Aging
ONCOTARGET
VIEW MORE ONCOTARGET ARTICLES ➜
ONCOSCIENCE
A Very Long, Winding Road: Developing Novel Therapeutics for Metastatic Tumors
“Given that the MET inhibitor capmatinib caused a remarkable response in Dr. Blagosklonny, a pertinent question remains as to why he was not treated with ‘preemptive drug combinations’ […]” BUFFALO, NY- February 23, 2024 – A new editorial paper was…
VIEW MORE ONCOSCIENCE ARTICLES ➜
GENES & CANCER
The Roles of USP1 in Ewing Sarcoma
“This study uncovered important roles for USP1 in Ewing sarcoma.” BUFFALO, NY- February 14, 2024 – A new research paper was published in Genes & Cancer on February 5, 2024, entitled, “Roles of USP1 in Ewing sarcoma.” Ewing sarcoma is…
Increased BRD4-L and BRD4-S Promotes Chemotherapy Resistance in Ovarian Carcinoma
“Overall, our work revealed a strong positive correlation between BRD4 overexpression status and chemoresistance in ovarian cancer […]” BUFFALO, NY- September 13, 2023 – A new research paper was published in Genes & Cancer on September 12, 2023, entitled, “Increased…
VIEW MORE GENES & CANCER ARTICLES ➜
NEWS
Impact Journals at AACR Annual Meeting 2024
BUFFALO, NY- March 11, 2024 – Impact Journals will be participating as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2024 from April 5-10 at the San Diego Convention Center in San Diego, California. This year,…
Ride for Roswell 2023: Team Open Access Recap
In a remarkable achievement, Impact Journals and Team Open Access contributed to an impressive total raise of $5.6 million (and the amount continues to grow) for cancer research through the Ride for Roswell. This outstanding outcome is a testament to…
Impact Journals Sponsors 2023 Ride for Roswell
Impact Journals is sponsoring Team Open Access in the annual cycling event to end cancer: The Ride for Roswell. This fundraiser is hosted by Roswell Park Comprehensive Cancer Center in Buffalo, New York. — BUFFALO, NY- June 19, 2023 –…